Justin A. Ezekowitz Journalist Profile

Articles

Rethinking Composite Endpoints with the Win Ratio: A Breakthrough or Business as Usual?

Jul 26, 2024 | onlinecjc.ca | Nicholas Grubic |Justin A. Ezekowitz

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy:

Apr 8, 2024 | jacc.org | James L. Januzzi |Javed Butler |Stefano Del Prato |Justin A. Ezekowitz

References1. "Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association". Diabetes Care . 2022;45:7: 1670-1690. 2. "High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes". Diabetologia . 2012;55:8: 2154-2162. 3.
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial - Nature Medicine

Aug 27, 2023 | nature.com | Barry A. Borlaug |Eric Barros |Sanjiv Shah |Subodh Verma |Walter P. Abhayaratna |Justin A. Ezekowitz | +5 more

AbstractIn the STEP-HFpEF trial, semaglutide improved symptoms, physical limitations and exercise function and reduced body weight in patients with obesity phenotype of heart failure and preserved ejection fraction (HFpEF).
People, Systems and Results matter in Heart Failure: Time for a change

Jul 28, 2023 | onlinecjc.ca | Justin A. Ezekowitz

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Give a Nudge a Shot: NUDGE-FLU bridging the Cardiovascular Quality Chasm

Jul 4, 2023 | pubmed.ncbi.nlm.nih.gov | Ezekowitz JA |Safia Chatur |Justin A. Ezekowitz

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Give a nudge a shot: NUDGE‐FLU bridging the cardiovascular quality chasm

Jul 4, 2023 | onlinelibrary.wiley.com | Safia Chatur |Justin A. Ezekowitz

Invited Editorial The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2913 References 1, , . The answer is 17 years, what is the question: Understanding time lags in translational research. J R Soc Med 2011; 104: 510– 520. https://doi.org/10.1258/jrsm.2011.110180 2, . Behavioral nudges are used widely to steer clinicians and patients alike.
Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3

Apr 5, 2023 | jacc.org | Stephen Greene |Johann Bauersachs |Jasper J. Brugts |Justin A. Ezekowitz

JACC Journals › JACC › Archives › Vol. 82 No. 6 AbstractDespite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population.
For Heart Failure, Sodium Restriction Not Supported for Reducing Mortality or Hospitalization

Feb 24, 2023 | newsbreak.com | Justin A. Ezekowitz

Restricting sodium intake often is recommended for patients with HF, based on basic and clinical models that have pointed to a role for sodium and ...
For Heart Failure, Sodium Restriction Not Supported for Reducing Mortality or Hospitalization

Feb 24, 2023 | physiciansweekly.com | Rebecca Shover |Justin A. Ezekowitz

Restricting sodium intake often is recommended for patients with HF, based on basic and clinical models that have pointed to a role for sodium and fluid handling in the pathophysiology of the condition. However, the clinical evidence underlying this practice is inconsistent, and as a result, clinicians treating patients with HF are faced with varying recommendations about dietary sodium intake in guidelines from major organizations (Table).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Justin A. Ezekowitz

Articles

Rethinking Composite Endpoints with the Win Ratio: A Breakthrough or Business as Usual?

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy:

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial - Nature Medicine

People, Systems and Results matter in Heart Failure: Time for a change

Give a Nudge a Shot: NUDGE-FLU bridging the Cardiovascular Quality Chasm

Give a nudge a shot: NUDGE‐FLU bridging the cardiovascular quality chasm

Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3

For Heart Failure, Sodium Restriction Not Supported for Reducing Mortality or Hospitalization

For Heart Failure, Sodium Restriction Not Supported for Reducing Mortality or Hospitalization

Contact details

Emails

Socials & Sites